Topics

Long-Term Data Highlight Poor Prognosis With TP53-Mutant MCL

15:37 EDT 11 Oct 2019 | OncLive

Ezzat Elhassadi, MD, discusses the results from a 10-year institutional analysis and how the presence of a TP53 mutation can correlate with survival outcomes in patients with mantle cell lymphoma

Original Article: Long-Term Data Highlight Poor Prognosis With TP53-Mutant MCL

NEXT ARTICLE

More From BioPortfolio on "Long-Term Data Highlight Poor Prognosis With TP53-Mutant MCL"

Quick Search